Back

How to estimate risk for cardiotoxicity in clinical practice.

28 August 2021 (09:30 - 09:41)
Organised by:
Congress Presentation Part of: Cardiotoxicity of cancer therapy: a clinical update Cardiovascular Disease in Specific Populations Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Alexander Lyon

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
How to diagnose cardiotoxicity of anticancer treatment.
Professor J. Zamorano Gomez (Madrid, ES)
Slides Video
Presentation thumbnail
How to monitor cardiovascular toxicity of anticancer treatment.
Professor B. Popescu (Bucharest, RO)
Slides Video
Presentation thumbnail
Cardiotoxicity of cancer therapy: a clinical update – discussion.
Video
Presentation thumbnail
Cardiotoxicity of cancer therapy: a clinical update - Chat Moderator.

Access the full session

Session thumbnail
Cardiotoxicity of cancer therapy: a clinical update
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 09:30 CET
You may be interested in
thumbnail
Webinar
The essential skill in cardio-oncology: baseline cardiotoxicity risk stratification
8 March 2021
thumbnail
Congress Presentation
The predictive value of inotropic reserve in risk stratification of cancer patients with antineoplastic therapy-induced cardiotoxicity
20 June 2025
thumbnail
Congress Presentation
Assessment of ESC risk stratification for cancer therapy-related cardiovascular toxicity in a real-world urban population
1 September 2025
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources